HIGHLIGHTS OF A CME/CE CERTIFIED SUPPLEMENT TO SKIN DISEASE EDUCATION FOUNDATION’S 40th Annual Hawaii Faculty Joseph F. Fowler, Jr, MD Clinical Professor of Dermatology University of Louisville Dermatology Louisville, Kentucky Theodore Rosen, MD ™ Professor of Dermatology Baylor College of Medicine Seminar A CONTINUING MEDICAL EDUCATION CONFERENCE Houston, Texas Jeffrey M. Sobell, MD Assistant Professor of Dermatology Tufts University School of Medicine Introduction Director, Psoriasis Treatment Center SkinCare Physicians Chestnut Hill, Massachusetts Update on TNF Inhibitors Nowell Solish, MD, FRCP(C) in Dermatology Assistant Professor University of Toronto Facial Dermatitis and Rosacea Toronto, Ontario, Canada Linda F. Stein Gold, MD Tinea and Onychomycosis Director of Dermatology Research Henry Ford Health System Acne: What’s New Detroit, Michigan Christopher B. Zachary, MBBS, FRCP Fillers: What’s Here and What’s Ahead Professor and Chair Department of Dermatology University of California, Irvine The Aging Face: Global Approach Irvine, California With Fillers and Neuromodulators Facial Rejuvenation: 40th Anniversary Review Post-Test and Evaluation Form Original Release Date: June 2016 • Expiration Date: June 30, 2017 Estimated Time to Complete Activity: Update to 2.33 hours Jointly provided by Supported by educational grants from AbbVie Inc., Bayer Healthcare, Merz North America Inc., and Valeant Pharmaceuticals North America LLC A CME/CE CERTIFIED SUPPLEMENT TO HIGHLIGHTS OF SKIN DISEASE EDUCATION FOUNDATION’S 40th Annual Hawaii Dermatology ™ Seminar Reprinted from A CONTINUING MEDICAL EDUCATION CONFERENCE Seminars in Cutaneous Medicine and Surgery The manuscript was originally published as a supplement to Seminars in Cutaneous Medicine and Surgery, Vol. 35, No. 4S, June 2016. It has been reviewed and approved by the faculty as well as the Editors Table of Contents of Seminars in Cutaneous Medicine and Surgery. Introduction .................................................................... 5 This continuing medical education Joseph F. Fowler, Jr, MD (CME/CE) supplement was developed Christopher B. Zachary, MBBS, FRCP from faculty presentations at the Skin Disease Education Foundation’s 40th Annual Hawaii Dermatology Update on TNF Inhibitors ............................................ 6 Seminar™, February 14-19, 2016. The in Dermatology Guest Editors/Faculty acknowledge the editorial assistance of Global Jeffrey M. Sobell, MD Academy for Medical Education, LLC, and Josh Kilbridge, medical writer, in Facial Dermatitis ........................................................... 9 the development of this supplement. The manuscript was reviewed and and Rosacea approved by the Guest Editors as well Joseph F. Fowler, Jr, MD as the Editors of Seminars in Cutaneous Medicine and Surgery for publication as a supplement to the journal. Tinea and Onychomycosis ......................................12 This activity was developed under Theodore Rosen, MD the direction of the Faculty/Guest Editors, Global Academy for Medical Education, and Rutgers. The ideas and Acne: What’s New .......................................................16 opinions expressed in this supplement Theodore Rosen, MD are those of the Guest Editors and do not necessarily reflect the views of the supporters, Global Academy for Fillers: What’s Here ......................................................19 Medical Education, Rutgers, or and What’s Ahead the Publisher. Nowell Solish, MD, FRCP(C) Copyright © 2016 by Global Academy for Medical The Aging Face: ..........................................................22 Education, LLC; Rutgers, The State University of New Jersey; and its Licensors. All rights reserved. No part of this publication may be reproduced or Global Approach transmitted in any form, by any means, without prior written permission of the Publisher. Global With Fillers and Academy for Medical Education, LLC, and Rutgers will not assume responsibility for damages, loss, Neuromodulators or claims of any kind arising from or related to the information contained in this publication, including Nowell Solish, MD, FRCP(C) any claims related to the products, drugs, or services mentioned herein. Facial Rejuvenation: ..................................................24 40th Anniversary Review Christopher B. Zachary, MBBS, FRCP Post-Test and Evaluation Form ................................27 2 globalacademycme.com/dermatology • Highlights of Skin Disease Education Foundation’s 40th Annual Hawaii Dermatology Seminar Highlights of Skin Disease Education Foundation’s 40th Annual Hawaii Dermatology Seminar Original Release Date: June 2016 • Implement updated strategies for managing acne, rosacea, and psoriasis Expiration Date: June 30, 2017 • Discuss the use of biologic agents in the treatment of adult and pediatric psoriasis Estimated Time to Complete Activity: Up to 2.33 hours • Review the status of biosimilars for use in dermatology Participants should read the CE information below, review the activity in its entirety, • Incorporate the recent advances in the treatment of acne vulgaris and complete the online post-test and evaluation. Upon completing this activity as • Discuss the safety, efficacy, and dosing of antibiotics for acne vulgaris designed and achieving a passing score on the post-test, you will be directed to a • Analyze emerging treatments for tinea and onychomycosis Web page that will allow you to receive your certificate of credit via e-mail or you • Identify the considerations in the selection of appropriate filler agents for treating may print it out at that time. different areas of the face • Compare and contrast the efficacy and safety of agents, devices, and techniques The online post-test and evaluation can be accessed at http://tinyurl.com/ currently available in aesthetic and procedural dermatology HDS16Supp. • Determine the appropriate nonsurgical techniques for facial rejuvenation Inquiries may be directed to Global Academy for Medical Education at • Describe the appropriate use of neuromodulators in the treatment of the aging face. [email protected] or (973) 290-8225. Disclosure Declarations Accreditation Statements Individuals in a position to control the content of this educational activity are required Physicians: This activity has been planned and implemented in accordance with to disclose: 1) the existence of any relevant financial relationship with any entity the Essential Areas and Policies of the Accreditation Council for Continuing Medical producing, marketing, re-selling, or distributing health care goods or services consumed Education (ACCME) through the joint providership of Rutgers, The State University by, or used on, patients with the exemption of non-profit or government organizations of New Jersey and Global Academy for Medical Education. Rutgers, The State and non-health care related companies, within the past 12 months; and 2) the identi- University of New Jersey is accredited by the ACCME to provide continuing medical fication of a commercial product/device that is unlabeled for use or an investigational education for physicians. use of a product/device not yet approved. Rutgers, The State University of New Jersey designates this enduring material for Faculty a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the Joseph F. Fowler, Jr, MD, Consultant: Bayer Healthcare, Galderma Laboratories, L.P., credit commensurate with the extent of their participation in the activity. GlaxoSmithKline, Johnson & Johnson, Medimetriks Pharmaceuticals, Inc., Ranbaxy Nurses: Rutgers, The State University of New Jersey, Center for Continuing and Outreach Laboratories Ltd., SmartPractice Dermatology/Allergy, Valeant Pharmaceuticals Education (CCOE) is an approved provider of continuing nursing education by the North America LLC; Speakers Bureau: Galderma, SmartPractice, Valeant; Grant/ New Jersey State Nurses Association, an accredited approver by the American Nurses Research Support: AbbVie Inc., Allergan, Inc., Amgen Inc., Anacor Pharmaceuticals, Credentialing Center’s Commission on Accreditation. Provider Number P173-5/31/16. Inc., Bayer, Celgene Corporation, Centocor, Inc., Chugai Pharma USA, Inc., Dow This activity is awarded 2.33 contact hours. (60 minute CH) Chemical Company, Eli Lilly and Company, Galderma, Genentech, Inc., Innovaderm Research Inc., Janssen Biotech, Inc., Johnson & Johnson, Merck & Co., Inc., Nurses should only claim those contact hours actually spent participating in the activity. Novartis Pharmaceuticals Corporation, Onset Dermatologics, LLC, Pfizer Inc., Target Audience Precision Dermatology, Regeneron Pharmaceuticals, Inc., SmartPractice, Taisho This supplement is intended for dermatologists, family practitioners, internists, Pharmaceutical Co., Ltd., Taro Pharmaceutical Industries Ltd., Valeant nurse practitioners, nurses, physician assistants, and other clinicians who practice Theodore Rosen, MD, Scientific Advisory Board: Anacor Pharmaceuticals, Inc., Merz medical dermatology or aesthetic medicine. North America Inc., Valeant Educational Needs Jeffrey M. Sobell, MD, Grant/Research Support: Amgen, Celgene, Eli Lilly, Janssen, Research continues to expand our understanding of the pathophysiology and Merck, Novartis; Consultant: AbbVie, Amgen, Celgene, Eli Lilly, Janssen; Speakers management of skin diseases and age-related skin damage. Based on this Bureau: AbbVie, Amgen, Celgene, Janssen, Novartis evidence, new pharmacologic agents and medical devices continue to be